Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-05-01 Anterior pituitary hormones
| Somapacitan |
|
Formulary
|
Growth hormone deficiency in people 3 to 17 years |
 NICE TA1066: Somapacitan for treating growth hormone deficiency in people 3 to 17 years |
|
Links
LSCMMG: Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes- LSCMMG: Somatropin Prescriber Information Leaflet
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- NHSE guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence
- NICE CG156: Fertility problems: assessment and treatment
- NICE TA1066: Somapacitan for treating growth hormone deficiency in people 3 to 17 years
- NICE TA188: Human growth hormone (somatropin) for the treatment of growth failure in children
- NICE TA188: Human growth hormone (somatropin) for the treatment of growth failure in children
- NICE TA64: Growth hormone deficiency (adults)
- NICE TA64: Human growth hormone (somatropin) in adults with growth hormone deficiency
- NICE TA863 Somatrogon for treating growth disturbance in children and young people aged 3 years and over